Free Trial

Phathom Pharmaceuticals (PHAT) SEC Filings & 10K Form

Phathom Pharmaceuticals logo
$8.78 -0.31 (-3.41%)
(As of 11/15/2024 ET)

Recent Phathom Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/12/2024
10:46 AM
BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G
11/07/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
3:12 PM
Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G/A
11/05/2024
2:32 PM
Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G
11/04/2024
10:20 AM
JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G
08/22/2024
3:05 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13D/A
08/19/2024
4:12 PM
Phathom Pharmaceuticals (Filer)
Form 424B5
08/19/2024
4:13 PM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
5:05 AM
Phathom Pharmaceuticals (Subject)
Form FWP
08/08/2024
7:06 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
1:52 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
1:50 PM
Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
1:51 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
12:59 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13D/A
05/31/2024
5:37 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:34 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:33 PM
KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:43 PM
FIELDS HEIDI (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:44 PM
COLA MICHAEL F (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:46 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:47 PM
Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:14 PM
Phathom Pharmaceuticals (Issuer)
Socks David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:18 PM
Phathom Pharmaceuticals (Issuer)
Stenhouse Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:03 PM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:30 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
5:10 AM
Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13D/A
04/01/2024
5:15 AM
Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13D/A
03/26/2024
3:05 PM
Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
7:06 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2024
3:00 PM
Phathom Pharmaceuticals (Subject)
Form SC 13G/A
01/26/2024
3:00 PM
Medicxi Growth I LP (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G/A
01/25/2024
5:13 AM
Phathom Pharmaceuticals (Issuer)
TAKEDA PHARMACEUTICAL CO LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:11 AM
Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13D/A
01/22/2024
7:19 PM
Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
7:21 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
7:22 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

12/14/2023
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
7:06 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2023
3:40 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2023
11:15 PM
Phathom Pharmaceuticals (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PHAT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners